Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW
2,205.00
-65.00 (-2.86%)
At close: Mar 31, 2025, 3:30 PM KST
Genome & Company Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 73,051 | 85,207 | 176,209 | 245,897 | 468,827 | 1,048,465 | |
| Market Cap Growth | -51.64% | -51.64% | -28.34% | -47.55% | -55.28% | 224.28% | |
| Enterprise Value | 75,781 | 89,070 | 151,242 | 185,907 | 383,841 | 1,026,945 | |
| Last Close Price | 2350.00 | 2750.00 | 6245.00 | 8725.00 | 17350.00 | 39750.00 | |
| PS Ratio | 2.58 | 3.07 | 12.33 | 17.46 | 1038.96 | 6962.78 | |
| PB Ratio | 3.33 | 0.86 | 1.55 | 1.63 | 4.13 | 9.11 | |
| P/TBV Ratio | 3.40 | 3.40 | 4.83 | 3.73 | 8.10 | 9.84 | |
| EV/Sales Ratio | 2.73 | 3.21 | 10.58 | 13.20 | 850.63 | 6819.87 | |
| Debt / Equity Ratio | 0.32 | 0.32 | 0.23 | 0.04 | 0.06 | 0.02 | |
| Asset Turnover | 0.18 | 0.18 | 0.09 | 0.09 | 0.00 | 0.00 | |
| Inventory Turnover | 2.59 | 2.59 | 3.53 | 4.76 | - | - | |
| Quick Ratio | 2.80 | 2.80 | 3.09 | 9.83 | 8.03 | 36.89 | |
| Current Ratio | 3.08 | 3.08 | 3.36 | 10.49 | 8.32 | 37.00 | |
| Return on Equity (ROE) | -25.26% | -25.26% | -38.36% | -43.15% | -31.51% | -80.88% | |
| Return on Assets (ROA) | -9.78% | -9.78% | -20.55% | -23.17% | -17.48% | -21.33% | |
| Return on Capital (ROIC) | -11.16% | -11.16% | -23.20% | -25.95% | -19.03% | -38.58% | |
| Earnings Yield | -27.53% | -23.60% | -26.94% | -21.08% | -7.28% | -2.93% | |
| FCF Yield | -27.79% | -23.82% | -28.99% | -20.50% | -6.19% | -1.88% | |
| Buyback Yield / Dilution | -7.86% | -7.86% | -0.37% | -4.71% | -39.60% | -20.11% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.